Coverage of the continuous glucose monitor for people with type 1 and insulin-requiring type 2 diabetes goes into effect on July 1, 2023. UnitedHealthcare, the largest health insurance company in the U.S., covers more than 45 million lives. Its offerings include health benefits, affordable coverage, a simplified healthcare experience and access to high-quality care.
Germantown, Maryland-based Senseonics designed its next-generation Eversense E3 CGM for long-term monitoring. The 180-day implantable CGM received FDA approval in February of last year.
Get the full story at our sister site, Drug Delivery Business News.